Clinical Trial Update: ELEVATE Early LEvosimendan Vs Usual Care in Advanced Chronic hearT failurE [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating early administration of levosimendan versus usual care in advanced chronic heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Niguarda Hospital | Conditions: Advanced Chronic Heart Failure | Phase 3 | Status: TERMINATED